HealthQuill Health
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.
Drugs Health Pharma

Researchers find new tech to change IV therapies into oral pills

HQ Team October 10, 2024: A study published in Nature Communications discusses a novel water-soluble prodrug technology called Sol-moiety, which enhances the oral bioavailability of.

Read More
As Hurricane Milton looms large over the Florida coast, weather climate researchers said rainfall caused by Hurricane Helene, which struck two weeks before, was amplified by about 10% and its winds by 11% due to climate change.
Climate Health Pharma

Climate change amplified US Hurricane Helene’s rainfall, winds

As Hurricane Milton looms large over the Florida coast, weather climate researchers said rainfall caused by Hurricane Helene, which struck two weeks before,.

Read More
Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years, according to the Pan American Health Organization.
Health Medical Pharma

Dengue cases at an all-time high in Americas Region: PAHO report

Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years,.

Read More
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season compared to 94.1% in the first and 64.2% in the second.
Drugs Health Pharma

GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year

GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season.

Read More
Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered company has halted its trials.
Drugs Health Pharma

Sage Therapeutics halts trials of experimental drug to treat dementia

Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered.

Read More
Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to a World Meteorological Organization report.
Climate Health Pharma

Global glaciers suffer largest mass loss in 50 yrs, 2023 driest for rivers

Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to.

Read More
AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to boost the North Chicago, Illinois-based company’s presence in the psychiatric and neurological disorder segment.
Climate Health Medical

Human life expectancy has hit its upper limits, says US research

HQ Team October 8, 2024:Humanity is hitting the upper limit of life expectancy, according to a new study. Medical advances have led to.

Read More
Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results
Drugs Health Medical

J&J stops trials on drug to treat muscle-invasive bladder cancer

Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results

Read More
The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Drugs Health Medical

Balancing gut bacteria can reduce inflammation in rheumatoid arthritis

HQ Team October 7, 2024: Rheumatoid arthritis (RA), an autoimmune disease that causes joint and bone inflammation, is affected by gut bacteria. Researchers.

Read More
UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza viruses.
Drugs Health Medical

UK’s DIOSynVax develops single candidate vaccine for bird flu virus

UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza.

Read More